Variegate porphyria (VP) is characterized by photocutaneous lesions and acute neuropsychiatric attacks. Decreased protoporphyrinogen oxidase activity results in accumulation of protoporphyrin(ogen) IX and coproporphyrin(ogen) III. During acute attacks delta-aminolevulinic acid and porphobilinogen also increase, suggesting that porphobilinogen deaminase (PBG-D) may be rate limiting. We have examined the effects of porphyrinogens accumulating in VP on PBG-D activity in Epstein-Barr virus-transformed lymphoblast sonicates from 12 VP and 12 control subjects. Protoporphyrinogen oxidase activity was decreased and protoporphyrin increased in VP lym- 
Introduction
Variegate porphyria (VP),' an autosomal dominant error of heme metabolism, is characterized by photocutaneous sensitiv-ity and a propensity to develop acute neuropsychiatric attacks with abdominal pain, vomiting, constipation, tachycardia, hypertension, psychiatric symptoms, and, in the worst cases, symmetrical quadriplegia (1) (2) (3) .
VP is associated with a defect ofthe penultimate heme synthetic enzyme, protoporphyrinogen oxidase (4) (5) (6) (7) (8) . This results in accumulation of the distal heme synthetic intermediates protoporphyrin(ogen) IX and coproporphyrin(ogen) III.
During acute attacks porphyrin(ogen) concentrations become even higher and, in addition, delta-aminolevulinic acid (ALA) and porphobilinogen (PBG), proximal intermediates of the heme synthetic pathway, increase ( 1, 2, 9) .
Acute attacks also occur in two other forms of porphyria, acute intermittent porphyria and hereditary coproporphyria (10) . Although the site of the inherited enzyme defect varies, PBG deaminase in acute intermittent porphyria (1 1, 12), coproporphyrinogen oxidase in hereditary coproporphyria ( 13, 14) , and protoporphyrinogen oxidase in VP, neuropsychiatric attacks in all three acute porphyrias are associated with elevated concentrations of ALA and PBG (10) .
The elevated concentrations of ALA and PBG are easily explained in acute intermittent porphyria. However, this finding does not tally with the known enzyme abnormality in VP and hereditary coproporphyria. The thesis that ALA and PBG are increased as a result of sequential damming up of products proximal to a block in the distal portion of the heme synthetic pathway is unlikely since increased concentrations ofALA and PBG are not found in porphyria cutanea tarda despite accumulation of large amounts of uroporphyrin(ogen) III, the intermediate immediately distal to PBG ( 10, (15) (16) (17) . Similarly it is unlikely that subjects with VP and hereditary coproporphyria have a second inherited defect at the level of PBG deaminase since the heme biosynthetic enzymes appear to be encoded on different chromosomes (9) .
In this study we examine the hypothesis that the obligate heme precursors that accumulate in VP (and in hereditary coproporphyria) inhibit PBG deaminase activity and result in rate-limiting effects. We have tested this hypothesis by performing a series of kinetic analyses of PBG deaminase using EBV-transformed lymphocytes from normal and VP subjects. Various porphyrins and porphyrinogens were assessed for their ability to alter kinetic behavior ofboth lymphoblast PBG deaminase and the purified enzyme.
Sonicates of lymphoblasts derived from subjects with VP exhibit a significant decrease in PBG deaminase Vma activity and display abnormal sigmoidal PBG deaminase substrate-velocity curves with kinetic features suggestive ofallosteric inhibition. These changes could be abolished by chromatography aimed at removing porphyrin(ogen)s from the PBG deaminase-containing fraction of VP lymphoblast sonicates and reproduced by addition of protoporphyrinogen IX and copro-phyrins) to sonicates of lymphoblasts from normal subjects. (Unless otherwise stated protoporphyrin [ogen] refers to the series IX isomer, and coproporphyrin [ogen] and uroporphyrin [ogen] refer to the series III isomers.) Finally, kinetic changes similar to those found in VP lymphoblasts were found when protoporphyrinogen was added to purified human PBG deaminase, suggesting that protoporphyrinogen has a direct effect on PBG deaminase activity.
Methods
Subjects. 12 healthy control and 12 quiescent VP subjects were used as lymphocyte donors in this study. All were defined clinically and by quantitative thin-layer chromatographic fluoroscanning of stool, urine, and plasma (18, 19) . The VP subjects all had stool protoporphyrin concentrations > 200 nmol/g dry wt and coproporphyrin concentrations > 50 nmol/g dry wt. Control subjects were asymptomatic, had no family history of porphyria, and exhibited normal porphyrin biochemistry. All subjects gave informed consent for the use of their blood, urine, and stool in this study.
EB V-transformedlymphoblastpreparation. EBV-transformed lyrmphoblasts were used in this study, since these cells could be derived from a relatively small amount ofwhole blood, they were easy to establish in culture, and once established from each original specimen, they readily yielded the large numbers of cells required for kinetic studies (6) . Most importantly, studies aimed at validating the lymphoblast system as a "model" of VP tissue allowed us to confidently assume the "VP" nature of these cells (see below).
20 ml of blood from each subject was taken into heparin. Lymphocytes were isolated, cultured, and prepared for assay as previously described (6) . Medium containing EBV was prepared from semiconfluent cultures of the EBV-producing marmoset cell line B95/8 (20) .
Protoporphyrinogen oxidase activity assay. Lymphoblast protoporphyrinogen oxidase was assayed as previously described (6) . Protoporphyrinogen solution (produced by treating protoporphyrin with 4% sodium amalgam) was added at five different concentrations (ranging between 0.75 and 2.5 AM), to a lymphoblast sonicate, and reaction buffer (50 mM Tris-HCI pH 8.5, 1 mM EDTA, 3 mM dithiothreitol, and 1% Brij-35). The reaction was allowed to proceed in the dark for 1 h at 370C. Protoporphyrin concentrations were measured by direct fluorometry (model 204A fluorescence spectrophotometer; PerkinElmer Cetus Instruments, Norwalk, CT). Nonenzymatic production ofprotoporphyrin was controlled for by measuring spontaneous protoporphyrin production under similar conditions. The rate of nonenzymatic oxidation of protoporphyrinogen was subtracted from the enzymatic rate. Apparent V. and Km values for protoporphyrinogen oxidase were determined from double-reciprocal Lineweaver-Burk plots. All assays were performed in duplicate.
PBG deaminase activity assay. PBG deaminase activity in lymphoblasts was measured by minimal adaptation of previously described methods for measuring erythrocyte and lymphocyte PBG deaminase activity (21) (22) (23) (24) (25) .
Lymphoblasts were prepared for assay in reaction buffer (0.1 M Tris-HCl pH 8.2 and 0.1 mM dithiothreitol added fresh) as described above. PBG deaminase was released by sonication. Sonicates were centrifuged at 30,000 g for 45 min and the supernatants were used for assay. The reaction mixture contained 100 td of sample and 600 Jl of reaction buffer. PBG concentrations were selected to straddle the reported Km of PBG deaminase (22, (25) (26) (27) ( 18, 19) .
Preparation and stability ofporphyrinogens for use in kinetic assays. Protoporphyrinogen, coproporphyrinogen, and uroporphyrinogen (all porphyrins from Porphyrin Products, Inc., Logan, UT) for addition to PBG deaminase assay systems (lymphoblast sonicates or purified PBG deaminase) were prepared by reduction of the corresponding porphyrin using 4% sodium amalgam that was freshly prepared using well-described methods (28, 29) .
A potential problem related to the known instability of porphyrinogens: because testing of the hypothesis demanded that porphyrinogens be investigated, it was necessary to examine the stability of various porphyrinogens under assay conditions. The relative stability of proto-, copro-, and uroporphyrinogen under PBG deaminase assay conditions was studied as follows: 5 ml of a 50 jiM solution of the appropriate porphyrin was reduced to the porphyrinogen using 4% sodium amalgam. The reduced solution was filtered and the pH was adjusted to 7.5 with glacial acetic acid. 2 ml of this was added to 8 ml of PBG deaminase assay buffer and the solution incubated for 12 h at 37°C in a shaking water bath in the dark for 2 h. A l-ml aliquot was removed every 15 min and its fluorescence was measured in a fluorometer. After 2 h any porphyrinogen present in the remaining volume was reoxidized by adding 50 Al of a 0.005% (wt/vol) aqueous iodine solution. A small crystal of cysteine was added to decolorize the excess iodine (28) . Oxidation of porphyrinogens as judged by reappearance of porphyrin fluorescence was negligible over the first 30 min and very slight over the next 90 min. Protoporphyrinogen was the least stable ( 14% reoxidation after 120 min), and uroporphyrinogen was the most stable (4% reoxidation after 120 min). It was concluded that the stability of the porphyrinogens under the proposed assay conditions was acceptable.
Addition of porphyrin(ogens) in the kinetic assays. Protopor-phyrin, coproporphyrin, and uroporphyrin were added to lymphoblast sonicate incubation mixtures 5 min before the assay ofPBG deaminase activity. All additions were designed to achieve incubation mixture porphyrin concentrations of 1, 5, and 10 MM. Protoporphyrinogen, coproporphyrinogen, and uroporphyrinogen were added immediately after their preparation by reduction using 4% sodium amalgam.
In a preliminary study we compared two assay methods: direct fluorometry of a 1/ 10 dilution of reaction mixture yielded a mean PBG deaminase Vmax of26.2+4.1 pmol/mg protein per h whereas extraction and quantitative porphyrin TLC gave a mean V,., of 28.0±2.1 pmol/ mg protein per h. A comparison of these two methods showed a marginally lower V. with a slightly larger scatter using the first method, although the two results were not statistically different (P = 2.300 X 10-', n = 6). Furthermore, thin-layer chromatographic analysis indicated similar quantities of copro-and protoporphyrin both before and after assay, whereas the amount of uroporphyrin increased. It was concluded that the use of fluorescence readings on diluted aliquots of reaction mixture was acceptable for the purposes of this study.
Removal ofporphyrin(ogen)sfrom PBG deaminase in VPlymphoblasts. After sonication of VP lymphoblasts, Sephadex G25 (Pharmacia LKB Biotechnology Inc., Uppsala, Sweden) chromatography was used to separate the low molecular weight endogenous porphyrin(ogen)s from fractions containing PBG deaminase activity. Fractions containing PBG deaminase were used for subsequent kinetic studies.
To validate the separation of porphyrins and PBG deaminase, a mixture of 0.5 mM uro-, copro-, and protoporphyrin was added to 10,000 g supernatants of control lymphoblast sonicates to ensure visible porphyrin fluorescence in the resulting porphyrin containing fractions eluted from the column. PBG deaminase activity was found to elute in the G25 void whereas porphyrins eluted at 3.2-3.4 times the void volume.
Next, supernatants (10,000 g) of sonicated VP lymphoblasts were applied to a 1.5 X 10 cm Sephadex G25 column, equilibrated with 0.1 M Tris-HCI buffer (pH 8.2), and eluted, with the same buffer, at a flow rate of 40 ml/h. Fractions containing PBG deaminase activity were pooled, concentrated on Centricon-30 (Amicon, Beverly, MA) columns through a P30 membrane, and assayed for protein content before PBG deaminase assay.
Purification ofPBG deaminase. PBG deaminase was purified from human erythrocytes using a procedure adapted from two previously published methods (27, 30) . Our purification data have recently been published (31) . The clear single protein band obtained with silver staining was estimated to have a molecular mass of41,200 D (±2,300) and the final specific activity of 241 nmol uroporphyrin formed/mg per h represented -7, 100-fold purification.
Addition ofporphyrinogen and porphyrin to purified PBG deaminase. Substrate-velocity data were obtained over a 1.25-20MOM concentration range of PBG at protoporphyrinogen concentrations of 0.01, 0.05, 0.1, 0.5, 1, 5, and 10 M. The effect ofadded protoporphyrin was assessed at 0.1, 1, and 10 MM concentrations. All enzyme assays were performed in duplicate.
Kinetic analysis and statistics. Data obtained from assays of PBG deaminase reaction velocity at different substrate concentrations using lymphoblasts were initially treated by application of Michaelis-Menten equation (32) to obtain VP Vm.,, and Km. Data which did not conform to the Michaelis-Menten rate law were examined using the Hill equation (33) . A nonlinear least-squares grid search procedure computed the following parameters from the Hill equation, which were used for comparative purposes: Vm,,, Ko.5, and the Hill coefficient, n.
Vn, is the maximal catalytic rate (velocity) for PBG deaminase, K0.5 is the substrate concentration at which halfmaximal velocity is achieved. The Hill coefficient describes the extent of cooperativity for ligandbinding processes or the extent to which multiple ligand-binding sites interact. The coefficient n, is always less than the actual number of ligand-binding sites (34 When heme biosynthesis in lymphoblast cell lines was stimulated by growing in the presence of 0.6 mM ALA for 24 h before harvesting according to previously described methods (21, 22) , VP cell lines had significantly higher concentrations ofboth protoporphyrin (30% increased, P = 2.163 X 10-) and coproporphyrin (14% increased, P = 3.254 x I0-3) than control cells.
PBG deaminase kinetics in control and VP lymphoblasts.
Lymphoblast sonicate PBG deaminase from 12 control subjects gave a mean Vma, of25.2±1.7 pmol/mg protein per h and a mean Km of 8.1±0.7 AM when evaluated by double-reciprocal substrate vs velocity (Lineweaver-Burk) plots. Linearity of the Lineweaver-Burk plot and ofthe rate/ substrate concentration versus rate (Eadie) plot confirmed the adherence of PBG deaminase in lymphoblasts derived from normal subjects (control lymphoblasts) to the Michaelis-Menten rate law (Fig.  1 A) [PBG] (pM)
The distinctive sigmoidal substrate-velocity plot was once again observed, as were the trends in V. and K.5 ( Fig. 2 B and Table 1 ). Longer periods of preincubation in the presence of coproporphyrinogen showed no further changes to those measured after 5 min of preincubation. Addition of uroporphyrinogen and porphyrins to control lymphoblast sonicates. In contrast to the striking effects noted on the addition of proto-and coproporphyrinogen, uroporphyrinogen failed to influence the kinetic behavior of control lymphoblast PBG deaminase. There were no significant differences in V,,,., K0.5, the Hill coefficient (P > 0.05 in all cases), or in the shape of the substrate-velocity plot (Table 1) .
Similarly, the addition of 1, 5, or 10 MM proto-, copro-, or uroporphyrin had no effect on the kinetic behavior of PBG deaminase in 12 control lymphoblast sonicates (Table I) . Indeed, preincubating lymphoblast preparations with 10 AM proto-, copro-, and uroporphyrin for up to 1 h before assaying PBG deaminase also did not alter PBG deaminase behavior.
Addition ofporphyrinogens to VP lymphoblast sonicates. Addition of proto-and coproporphyrinogen to VP lymphoblast sonicates resulted in an exaggeration of the kinetic changes already present. Once again, protoporphyrinogen ap- ,MM protoporphyrinogen was greater than that obtained with 5 MAM protoporphyrinogen, which was in turn greater than that in the presence of 1 uM protoporphyrinogen, but none achieved significance.
As the concentration of protoporphyrinogen was increased over a 10-fold range, the Hill coefficient increased to approach a value of4 in the limit (Table 1 ) . Longer periods ofpreincubation in the presence of protoporphyrinogen appeared to exert no further effect on the kinetic behavior ofcontrol lymphoblast PBG deaminase.
Addition of 1, 5, and 10 ,M concentrations of coproporphyrinogen had a similar but less impressive effect on control lymphoblast PBG deaminase. As coproporphyrinogen concentrations were increased over a 10-fold range, V.. decreased by an average of 27% (P = 7.097 X 10-4) and the Hill coefficient appeared to approach 3 (in the limit). The mean of the K0.5 values between the lymphoblasts with additions and those without were not significantly different (P = 2.474 X 10-'). As in the control lymphoblasts, uroporphyrinogen failed to exert any additional effect on VP PBG deaminase kinetic behavior (Table II) . Furthermore, the addition of 1, 5, or 10 AM proto-, copro-, or uroporphyrin had no additional effect on the already anomalous kinetic behavior of PBG deaminase in 12 VP lymphoblast sonicates.
Kinetics of purified PBG deaminase. Substrate-velocity data ofpure PBG deaminase yielded a hyperbolic curve (Fig. 3 Sephadex G25 chromatography. PBG deaminase kinetics ofcontrol lymphoblast preparations were not changed by Sephadex G25 chromatography. In striking contrast, after Sephadex G25 chromatography, VP lymphoblast PBG deaminase substrate velocity data were identical to those of control lymphoblasts (Fig. 5) .
Discussion
Much of the evidence favoring our hypothesis that heme precursors that accumulate in VP inhibit PBG deaminase activity depends on the validity of the EBV-transformed lymphoblast system. Two lines of evidence suggest that the VP defect persists in this system. First, we have confirmed our previously published data that protoporphyrinogen oxidase activity in VP lymphoblasts is reduced by roughly 50% (6) . Second, and vital to our hypothesis, there was a significant increase in endogenous protoporphyrin concentration in our VP lymphoblast cultures. Indeed when porphyrin production was stimulated by addition of ALA to the culture medium both protoporphyrin(ogen) and coproporphyrin(ogen) concentrations in VP lymphoblasts exceeded those of similarly treated cells derived from control subjects.
Although diminished protoporphyrinogen oxidase activity has previously been demonstrated in fibroblasts from VP subjects, protoporphyrin(ogen) concentration in that system was not increased even after the addition ofALA (4). The elevated protoporphyrin concentrations found in our study suggest that in transformed lymphoblasts, the flux through the pathway may be high enough for the defect in protoporphyrinogen oxidase to become evident. Substrate-velocity data for PBG deaminase in lymphoblast sonicates were obtained by measuring the rate of formation of uroporphyrinogen at five substrate concentrations. Ideally these concentrations should fall both above and below the Km for the enzyme (33) so as to cover a wide range around the Vm,.. The literature reports Km values ranging between 6 and 22 AM (22, (25) (26) (27) 30) and our data indicated a Km (or the equivalent K0.5 using Hill analysis) of -8 AM for lymphoblast PBG deaminase originating from healthy control subjects. Thus the choice of PBG concentrations of 1.25, 2.5, 5, 10, and 20 MM is appropriate, since these substrate concentrations cover a range from 13 to 73% of V,.
Analysis of the data obtained in control lymphoblasts by the Michaelis-Menten equation yielded a V,, of 25.2±1.7 pmol/mg per h and a Km of 8.1±0.7 AM. There are only two previous reports of the measurement of PBG deaminase activity in lymphoblasts. One (25) reports an activity of 11 pmol/ mg protein per h for human lymphoblast lines, but it is unclear whether these were EBV-transformed lymphoblast lines. The other study (22) found values of 40 and 68 pmol/mg protein per h for PHA-or pokeweed-mitogen-stimulated lymphocytes and EBV-transformed lymphoblasts, respectively. It must be noted that reported erythrocyte PBG deaminase activities show a large range, which underscores the need to establish control values for each individual laboratory and method. Our control lymphoblast results appear to be of the same order as those in other reports and were thus considered valid for the purposes of this study.
Comparison of the indexes of kinetic behavior of VP lymphoblast PBG deaminase with that of control lymphoblasts yielded the unprecedented observation that although control PBG deaminase exhibited a hyperbolic substrate-velocity relationship suggesting enzyme substrate interaction at a single ligand-binding site, VP PBG deaminase did not (Fig. 1) .
Although the mechanism of action of PBG deaminase remains a subject of research activity and debate (37) (38) (39) , it is generally assumed that in most cases the appearance and rate of production of uroporphyrinogen from PBG by the enzyme follows the Michaelis-Menten rate law. There are, however, reports of nonMichaelian behavior from one group (26, 27, 40) . In our study, the impure preparations of PBG deaminase from control lymphoblasts exhibited classic Michaelis-Menten behavior. This was borne out by the linearity of the Lineweaver-Burk plot ( I /rate vs 1 /[substrate] ) and the Eadie plot (rate/[substrate] vs rate) (Fig. 1 A) .
The Hill equation (33) A Hill coefficient close to 1 implies that the enzyme has only one binding site or that multiple sites, if present, are identical and that the binding at any site is independent of the occupation of other sites. It is generally accepted that PBG deaminase exists in monomeric form and that there is only one substrate (ligand)-binding site (22, 30) . This is consistent with our value for control lymphoblasts.
The substrate-velocity data for VPlymphoblast PBG deaminase does not fit the Michaelis-Menten equation (Fig. 1 B) . The most striking difference was a sigmoidal substrate-velocity plot. Fortunately, the data fitted the Hill equation well. Using (Fig. 2 A) , decreased Vmax and changed the substrate-velocity plot to a sigmoidal form. Vm. decreased most after addition of 10 uM protoporphyrinogen and least after 1 uM protoporphyrinogen (Table I) were less marked than those produced by protoporphyrinogen.
For 1 and 5 ,uM coproporphyrinogen the Hill coefficient approached 2 and for 10,gM coproporphyrinogen approached 3.
Thus coproporphyrinogen may be a less "potent" negative effector. Addition of uroporphyrinogen or of porphyrin did not influence control lymphoblast PBG deaminase kinetics.
The similarity between the behavior of PBG deaminase in VP lymphoblasts and those observed in normal lymphoblasts after addition ofprotoporphyrinogen and coproporphyrinogen suggest that the sigmoidal curve of VP cell PBG deaminase might be related to intracellular accumulation of these heme intermediates. Ifthis were so, addition ofthese porphyrinogens to VP lymphoblast PBG deaminase preparations should enhance the changes already present. Our finding that additional protoporphyrinogen and coproporphyrinogen, but not uroporphyrinogen, proto-, copro-, or uroporphyrin, decreased V. and increased the Hill coefficient to levels not dissimilar to those obtained when 10 uM concentrations of proto-and coproporphyrinogen were added to normal lymphoblast sonicates is in keeping with this thesis.
To exclude any confounding effect associated with the use of less pure lymphoblast sonicates, a limited series of experiments were performed using purified human erythrocyte PBG deaminase. Our purification procedure, judged by silver staining of SDS-PAGE, yielded homogeneous PBG deaminase. The final specific activity, 241 nmol uroporphyrin formed/mg per h, was intermediate between the 2300 nmol/mg per h (25) and the 68 nmol/mg per h (27) reported by the two groups on whose techniques our method was based. Our -7,100-fold purification lies between the 3,400-fold (27) and 42,000-fold (25) reported by the two methods. The product ran on SDS-PAGE as a single unit of molecular weight 41,200 (±2,300).
Purified PBG deaminase, in the absence of added porphyrinogen, behaved as a Michaelian enzyme with a single substrate-binding site. Addition ofprotoporphyrinogen to purified PBG deaminase once again resulted in a decreased Vma and a sigmoidal substrate-velocity curve. Once again, the Hill coefficient approached 4 ( Fig. 4 and Table III ). Both Vm. and the Hill coefficient were maximally affected at 10 uM protoporphyrinogen and tenuously affected at 0.01,M. Single exponential analysis of both Vm,. and the Hill coefficient against protoporphyrinogen concentration (Fig. 4) revealed that the concentrations at which the effects were half "maximal" were 1442 P. Meissner, P. Adams, and R. Kirsch Vmax (nmol/mg/h) almost identical. This strongly suggests that a single mechanism is responsible for affecting both Vm., and the degree of cooperativity. Addition of protoporphyrin had no effect on the kinetics of pure PBG deaminase. These findings using purified erythrocyte enzyme are so similar to those obtained using our lymphoblast sonicates that they suggest that both erythroid and nonerythroid forms of PBG deaminase are inhibited by protoporphyrinogen.
If the kinetic abnormalities observed in VP lymphoblasts are indeed due to intracellular accumulation of proto-and coproporphyrinogen, removal of these porphyrinogens from VP lymphoblasts should restore normal PBG deaminase kinetic behavior. After establishing that fractions containing PBG deaminase activity and those containing porphyrin(ogen)s could be separated by Sephadex G25 chromatography, this procedure was used to separate endogenous heme intermediates from VP lymphoblast fractions exhibiting reduced PBG deaminase activity. Single passage ofVP lymphoblast cytosolic preparations down a Sephadex G25 column resulted in restoration of"normal" kinetic behavior to PBG deaminase. Although it is possible that molecular sieving removed other factor(s) responsible for alteration of PBG deaminase behavior, these results are consistent with our hypothesis.
Finally, ifaccumulation of proto-and coproporphyrinogen affect PBG deaminase in VP, urinary ALA and PBG concentrations should be marginally elevated, even in quiescent VP. ALA and PBG levels have traditionally been considered to be "normal" in quiescent VP. We have measured urinary concentrations of these precursors in 221 patients with quiescent VP and 93 controls. Urinary ALA and PBG concentrations in quiescent VP subjects were 32.4±26.3 and 15.5±23.6 ,umol/ 10 mmol creatinine, 2.5 and 4.6 times higher, respectively, than those of control subjects (ALA 12.85±5.7, PBG 3.4±2.3) (P < 0.001). This increase in urinary ALA and PBG excretion suggests that the decrease in PBG deaminase Vm,,, is sufficient to perturb the heme synthetic processes even in quiescent VP.
The mechanism by which protoporphyrinogen and to a lesser degree coproporphyrinogen affect PBG deaminase is not known. Our data suggest that the ability ofthese intermediates to inhibit PBG deaminase may be related to the number of carboxyl groups on the porphyrinogen. Uroporphyrinogen had no effect, whereas the effect of coproporphyrinogen was less than that of protoporphyrinogen. Thus steric and/or hydrophobic effects may be important. Secondly, the lack of influence of porphyrins on PBG deaminase may be caused by the strongly aromatic nature of these compounds. This is in contrast to the unconjugated macrocyclic ring system of the porphyrinogens. In the porphyrins the conjugated pi-electron systems lie above and below the whole tetrapyrrolic macrocycle and may shield the porphyrin from potential interaction with the enzyme molecule. The porphyrinogens on the other hand are aliphatic and the aromaticity is confined to the individual pyrrolic "corners" (42) . This renders the interpyrrolic methylene groups more accessible.
Our data provide several lines of evidence to support our hypothesis that proto-and coproporphyrinogen exert negative allosteric effects on PBG deaminase. This may account for the increases of ALA and PBG seen when heme synthesis is depressed during the acute porphyric attack. Our study offers an explanation for the apparent defect in PBG deaminase in each of the acute porphyrias. In acute intermittent porphyria, PBG deaminase deficiency is inherited. In VP and hereditary coproporphyria, the intermediates accumulating as a result of the inherited enzyme defect may partially inhibit PBG deaminase. The finding that uroporphyrinogen exerted no influence on PBG deaminase is in keeping with our hypothesis, since porphyria cutanea tarda is a nonacute porphyria in which concentrations of ALA and PBG are not elevated despite greatly increased uroporphyrinogen concentrations.
